Arrowhead Pharmaceuticals · 2 weeks ago
Manager / Sr. Manager, Statistical Programming
Arrowhead Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing RNAi-based therapeutics for intractable diseases. They are seeking a Manager of Statistical Programming to provide technical leadership and statistical programming support for clinical studies, collaborating with various functional teams within the organization.
BiotechnologyHealth CareNanotechnologyPharmaceutical
Responsibilities
Review of analysis plans for appropriate methodologies
Review of clinical data as SDTM dataset
Development of analysis databases (ADaM)
Programming of study analyses and review of study results
Conduct ad-hoc and exploratory statistical analysis and support manuscript preparation
Communicate the project requirements for cleanup and data capture to ensure the key study variables are suitable for analysis
Assist in efforts to identify, develop and implement departmental standards, applications, processes and training; and
Assist in identifying consultants and the selection of service providers and oversees statistical and programming deliverables by CROs or service providers
Qualification
Required
Master's degree in Biostatistics/Statistics
4 years of relevant programming experience in pharmaceutical or biotechnology drug development
Proficiency in the use of statistical software including SAS, and familiarity of the use of R studio
Excellent verbal and written communication skills
Effective in communication and team collaboration, influencing across different functional lines
Understanding and experience with various aspects of a clinical development life-cycle, leading up to regulatory submission and post-approval activities
Experience interacting with and overseeing programming services of CRO vendors
Knowledge of cross-functional department functions/roles within a drug development company
Preferred
Understanding of regulatory guidelines related to submission of datasets using CDISC, development of SDTM and ADaM specifications
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Funding
Current Stage
Public CompanyTotal Funding
$2.45BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M
Leadership Team
Christopher Anzalone
President and Chief Executive Officer
Recent News
2026-01-14
2026-01-08
Company data provided by crunchbase